[HTML][HTML] Prognostic and immune infiltration signatures of proteasome 26S subunit, non-ATPase (PSMD) family genes in breast cancer patients

CC Wu, TJ Kao, HDK Ta, G Anuraga, V Andriani… - Aging (albany …, 2021 - ncbi.nlm.nih.gov
The complexity of breast cancer includes many interacting biological processes that make it
difficult to find appropriate therapeutic treatments. Therefore, identifying potential diagnostic …

Comprehensive analysis of PSMD family members and validation of PSMD9 as a potential therapeutic target in human glioblastoma

Y Li, X Liu, F Zhao, Z Zhao, X Li, J Wang… - CNS Neuroscience …, 2024 - Wiley Online Library
Aims PSMD family members, as important components of the 26S proteasome, are well
known to be involved in protein degradation. However, their role in glioblastoma (GBM) has …

26S proteasome Non-ATPase regulatory subunits 1 (PSMD1) and 3 (PSMD3) as putative targets for cancer prognosis and therapy

AJ Rubio, AE Bencomo-Alvarez, JE Young… - Cells, 2021 - mdpi.com
Ever since the ubiquitin proteasome system was characterized, efforts have been made to
manipulate its function to abrogate the progression of cancer. As a result, the anti-cancer …

Identification and validation of immune-related gene signature models for predicting prognosis and immunotherapy response in hepatocellular carcinoma

Z Liu, L Yang, C Liu, Z Wang, W Xu, J Lu… - Frontiers in …, 2024 - frontiersin.org
Background This study seeks to enhance the accuracy and efficiency of clinical diagnosis
and therapeutic decision-making in hepatocellular carcinoma (HCC), as well as to optimize …

The clinicopathological and prognostic significance of PSMD14 in cancers based on bioinformatics and meta-analysis

SY Dong, S Ding, Z Meng, B Zou - Future Science OA, 2024 - Taylor & Francis
Aim: To evaluate the clinic-pathological features and prognostic value regarding PSMD14 in
cancers. Materials & methods: Literature was gathered from public databases until 22 June …

Analysis and experimental validation of the innate immune gene PSMD1 in liver hepatocellular carcinoma and pan-cancer

X Chen, G Liu, B Wu - Heliyon, 2023 - cell.com
This work intends to examine the diagnostic, prognostic, and biological roles of PSMD1
(proteasome 26S subunit, non-ATPase 1) in liver hepatocellular carcinoma (LIHC) and other …

19S Proteasome subunits as oncogenes and prognostic biomarkers in FLT3-mutated acute myeloid leukemia (AML)

JJ Lara, AE Bencomo-Alvarez, MA Gonzalez… - International Journal of …, 2022 - mdpi.com
26S proteasome non-ATPase subunits 1 (PSMD1) and 3 (PSMD3) were recently identified
as prognostic biomarkers and potential therapeutic targets in chronic myeloid leukemia …

Proteasome 26S subunit, non-ATPase 1 (PSMD1) facilitated the progression of lung adenocarcinoma by the de-ubiquitination and stability of PTEN-induced kinase 1 …

L Liu, A Liu, J Dong, Z Zuo, X Liu - Experimental Cell Research, 2022 - Elsevier
Lung adenocarcinoma (LUAD) is the most metastatic, invasive, and fatal tumor type of non-
small cell lung cancer that lacks satisfying therapy. The purpose of this work is to investigate …

PSMD3 gene mutations cause pathological myopia

J Chen, P Lian, X Zhao, J Li, X Yu, X Huang… - Journal of Medical …, 2023 - jmg.bmj.com
Purpose Genetic factors play a prominent role in the pathogenesis of pathological myopia
(PM). However, the exact genetic mechanism of PM remains unclear. This study aimed to …

PSMD3-ILF3 signaling cascade drives lung cancer cell proliferation and migration

J Zhang, Q Ma, Q Yu, F Xiao, Z Zhang, H Feng, C Liang - Biology Direct, 2023 - Springer
Background Proteasome 26S subunit, non-ATPase 3 (PSMD3) has been reported to
participate in various human cancers. Nevertheless, the function of PSMD3 in lung cancer …